These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26415664)

  • 1. Strong correlation between the antifungal effect of amphotericin B and its inhibitory action on germ-tube formation in a Candida albicans URA⁺ strain.
    Guirao-Abad JP; González-Párraga P; Argüelles JC
    Int Microbiol; 2015 Mar; 18(1):25-31. PubMed ID: 26415664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1998 May; 27(5):213-9. PubMed ID: 9682984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
    Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
    J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
    Warnock DW; Johnson EM; Burke J; Pracharktam R
    J Antimicrob Chemother; 1989 Jun; 23(6):837-47. PubMed ID: 2547749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans.
    Kumar R; Shukla PK
    Fungal Biol; 2010; 114(2-3):189-97. PubMed ID: 20943129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans.
    Guirao-Abad JP; Sánchez-Fresneda R; Alburquerque B; Hernández JA; Argüelles JC
    Int J Med Microbiol; 2017 Jun; 307(4-5):241-248. PubMed ID: 28412040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of amphotericin B and flucytosine on hyphal growth of Candida albicans estimated at a single hypha level.
    Oh KB; Yang HC; Matsuoka H; Yamamoto A; Kurata H
    J Med Vet Mycol; 1995; 33(3):191-5. PubMed ID: 7666300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    Lignell A; Löwdin E; Cars O; Sjölin J
    J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M; Farag N; Khardori N
    Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5-fluorocytosine.
    Richardson MD; Paton M; Shankland GS
    Mycoses; 1991; 34(5-6):201-4. PubMed ID: 1795714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ; DeLallo VC; Lewis RE; Ernst EJ; Klepser ME
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of Coriandrum sativum essential oil, its mode of action against Candida species and potential synergism with amphotericin B.
    Silva F; Ferreira S; Duarte A; Mendonça DI; Domingues FC
    Phytomedicine; 2011 Dec; 19(1):42-7. PubMed ID: 21788125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans.
    Shadomy S; Shadomy HJ
    Diagn Microbiol Infect Dis; 1991; 14(1):21-2. PubMed ID: 2013207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacillomycin D and its combination with amphotericin B: promising antifungal compounds with powerful antibiofilm activity and wound-healing potency.
    Tabbene O; Azaiez S; Di Grazia A; Karkouch I; Ben Slimene I; Elkahoui S; Alfeddy MN; Casciaro B; Luca V; Limam F; Mangoni ML
    J Appl Microbiol; 2016 Feb; 120(2):289-300. PubMed ID: 26669801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.